Share
Journal Information
Most often read
17835
Position statement on the use of albumin in liver cirrhosisGraciela Castro-Narro, Carlos Moctezuma-Velázquez, Rene Male-Velázquez, Rafael Trejo-Estrada, Francisco Javier Bosques, Rosalba Moreno-Alcántar, Heriberto Rodríguez-Hernández, Aleida Bautista-Santos, ... Aldo Torre
Ann Hepatol. 2022;27:100708
17835
Open access
17005
Acid-base abnormalities and liver dysfunctionPeriklis Katopodis, Efthymios M. Pappas, Konstantinos P. Katopodis
Ann Hepatol. 2022;27:100675
17005
Open access
15252
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?Diego García-Compeán, Alan Rafael Jiménez-Rodríguez
Ann Hepatol. 2022;27:100765
15252
Full text access
10464
From Child-Pugh to MELD score and beyond: Taking a walk down memory laneAndres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
10464
Open access
10343
Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysisBabu Pappu Mohan, Sentia Iriana, Shahab Rasool Khan, Pradeep Yarra, Suresh Ponnada, Juan Fernando Gallegos-Orozco
Ann Hepatol. 2022;27:100741
10343
Full text access
9290
Current approaches to hepatic encephalopathyPaulina Vidal-Cevallos, Norberto C. Chávez-Tapia, Misael Uribe
Ann Hepatol. 2022;27:100757
9290
Full text access
9233
Clinical treatment of cholangiocarcinoma: an updated comprehensive reviewAlessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
9233
Open access
7577
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and CPegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
7577
Open access
7127
CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTSA.B. Moreno-Cobos, J.L. Pérez-Hernández, B.A. Enríquez-Constantino, M.Y Carmona-Castillo, E.J. Medina-Ávalos, C.L. Dorantes-Nava, M.F. Higuera-De la Tijera
Ann Hepatol. 2022;27 Supl 2:100589.12
7127
Open access
5851
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based studyOsama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
5851
Open access
5556
Management of COVID-19 patients with chronic liver diseases and liver transplantsXinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li
Ann Hepatol. 2022;27:100653
5556
Open access
4821
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis BTania Queiroz Reuter, Michele Gomes-Gouvea, Samira Chuffi, Ulisses Horst Duque, José Americo Carvalho, Waltesia Perini, Marcello Moro Queiroz, Ingrid Marques Segal, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100574
4821
Open access
4068
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in BrazilMarlone Cunha-Silva, Fernando L. Ponte Neto, Priscila S. de Araújo, Lucas V. Pazinato, Raquel D. Greca, Tirzah M.L. Secundo, Marcello R. Imbrizi, Leonardo T. Monici, ... Daniel F. Mazo
Ann Hepatol. 2022;27:100543
4068
Open access
3822
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver diseaseToshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Ann Hepatol. 2022;27:100699
3822
Open access
3791
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroidsSomayeh Shokri, Shahab Mahmoudvand
Ann Hepatol. 2022;27:100704
3791
Open access
3740
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in MexicoLuis E. Gomez-Quiroz, Sonia Roman
Ann Hepatol. 2022;27 Supl 1:100649
3740
Open access
3640
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseasesMahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
Ann Hepatol. 2022;27:100702
3640
Open access
3514
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shuntsQiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, ... Wuhua Guo
Ann Hepatol. 2022;27:100725
3514
Open access
3076
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidenceFranco Trevisani, Edoardo G. Giannini
Ann Hepatol. 2022;27 Supl 1:100564
3076
Open access
3025
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, Esmeralda Ismail, Vasiliki Kalampoka, Max Hilscher, Maurice Michel, Ekkehard Siegel, ... Christian Labenz
Ann Hepatol. 2022;27:100719
3025
Open access
Publish in
Annals of Hepatology
Affiliated societies
